David González de Castro

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial”.

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101435

N/A

0.457DataRank · unranked

20 citations

Richard Marais, Núria Porta, David González de Castro, Lisa Parsons, Christina Messiou +18 more

Enhanced Activity of Alzheimer Disease-associated Variant ofProtein Kinase Cα Drives Cognitive Decline

Research Square(2021)10.21203/rs.3.rs-894083/v1

N/A

0DataRank · unranked

1 citations

Jacob M. Wozniak, Kim Doré, Lara E. Dozier, Chelsea Cates‐Gatto, Gentry N. Patrick +5 more